Two Sigma Advisers’s Taysha Gene Therapies TSHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-87,700
| Closed | -$169K | – | 2704 |
|
|
2022
Q3 | $169K | Sell |
87,700
-18,100
| -17% | -$34.9K | ﹤0.01% | 2235 |
|
|
2022
Q2 | $394K | Sell |
105,800
-30,500
| -22% | -$114K | ﹤0.01% | 2026 |
|
|
2022
Q1 | $889K | Buy |
136,300
+102,200
| +300% | +$667K | ﹤0.01% | 1692 |
|
|
2021
Q4 | $397K | Buy |
+34,100
| New | +$397K | ﹤0.01% | 2026 |
|